GEP20084424B - Sedative and spasmolytic medicinal agent and method for the production thereof (variants) - Google Patents
Sedative and spasmolytic medicinal agent and method for the production thereof (variants)Info
- Publication number
- GEP20084424B GEP20084424B GEAP200510059A GEAP2005010059A GEP20084424B GE P20084424 B GEP20084424 B GE P20084424B GE AP200510059 A GEAP200510059 A GE AP200510059A GE AP2005010059 A GEAP2005010059 A GE AP2005010059A GE P20084424 B GEP20084424 B GE P20084424B
- Authority
- GE
- Georgia
- Prior art keywords
- cyclodextrine
- phenobarbital
- pill
- mixture
- medicinal agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to medicine. The inventive sedative and spasmolytic medicinal agent comprises an ά bromomethyl butanoic acid ethyl ether, phenobarbital, brandy mint oil, microcrystalline cellulose and adjuvants for forming solid dosage form (pills) which are coated with a shell containing ß cyclodextrine or the derivatives thereof. The first variant of a method for producing said medicinal agent consists in mixing the ά bromomethyl butanoic acid ethyl ether with the brandy mint oil, adding said mixture into the humidified ß cyclodextrine, stirring for 1-2 minutes, drying, granulating, in mixing the granulate with the phenobarbital, microcrystalline cellulose and adjuvant powders, pressing a pill and coating said pill with the ß cyclodextrine-containing shell. The second variant of said method consists in mixing the phenobarbital with the adjuvant-filler, separately preparing the mixture of the ά bromo-methyl butanoic acid ethyl ether and the brandy mint oil, adding the microcrystalline cellulose, developed crystal face powders, openers and sliding agents, in adding said mixture into the phenobarbital-filler mixture, pressing a pill and in coating said pill with the ß cyclodextrine-containing shell.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA20041008756A UA81623C2 (en) | 2004-10-26 | 2004-10-26 | A process for the preparation of the drug of sedative and spasmolytic action |
UA20041008755 | 2004-10-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
GEP20084424B true GEP20084424B (en) | 2008-07-10 |
Family
ID=36228091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GEAP200510059A GEP20084424B (en) | 2004-10-26 | 2005-10-26 | Sedative and spasmolytic medicinal agent and method for the production thereof (variants) |
Country Status (3)
Country | Link |
---|---|
GE (1) | GEP20084424B (en) |
RU (1) | RU2349334C2 (en) |
WO (1) | WO2006046933A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2563190C2 (en) * | 2012-06-14 | 2015-09-20 | Открытое Акционерное Общество "Татхимфармпрераты" | Medication based on dry extracts of medicinal plants and method of obtaining thereof (versions) |
EA021571B1 (en) * | 2013-04-17 | 2015-07-30 | Общество с ограниченной ответственностью "ЮжФарм" | Method for preparing tableted mass from active pharmaceutical substances having sedative and spasmolytic action |
RU2589833C2 (en) * | 2013-12-12 | 2016-07-10 | Общество С Ограниченной Ответственностью "Фарма Старт" | Solid dosage form of preparation of sedative and hypnotic effect |
RU2578432C9 (en) * | 2015-03-02 | 2016-06-20 | Общество с ограниченной ответственностью "Трейдсервис" | Method of obtaining a solid form of the drug sedative and antispasmodic action |
RU2633064C2 (en) * | 2015-09-18 | 2017-10-11 | Закрытое акционерное общество "Московская фармацевтическая фабрика" | Sedative and spasmolithic means and method for its production |
CN107582530A (en) * | 2017-06-01 | 2018-01-16 | 合肥远志医药科技开发有限公司 | A kind of Kotabarb and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0166088B1 (en) * | 1990-01-23 | 1999-01-15 | . | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
-
2005
- 2005-10-26 GE GEAP200510059A patent/GEP20084424B/en unknown
- 2005-10-26 RU RU2007118240/15A patent/RU2349334C2/en active
- 2005-10-26 WO PCT/UA2005/000046 patent/WO2006046933A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
RU2007118240A (en) | 2008-12-10 |
WO2006046933A1 (en) | 2006-05-04 |
RU2349334C2 (en) | 2009-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20084424B (en) | Sedative and spasmolytic medicinal agent and method for the production thereof (variants) | |
TW474825B (en) | Novel oral pharmaceutical formulations with multiple unit tableted dosage form and their process for preparation | |
WO2001056544A3 (en) | Shell-and-core dosage form approaching zero-order drug release | |
EP1274402B1 (en) | Pharmaceutical composition for the controlled release of paracetamol | |
CN104220050A (en) | Composite formulation comprising multi-unit spheroidal tablet (must) encapsulated in hard capsule and method for preparing same | |
HK1039070A1 (en) | Pharmaceutical formulation comprising omeprazole | |
BRPI0511710A (en) | calcium-containing tablet and dose dispensing cassette | |
PL1746980T3 (en) | Pharmaceutical dosage form comprising pellets as well as its manufacturing process | |
WO2002087546A3 (en) | Method for manufacturing a low dose pharmaceutical composition | |
CN104606163A (en) | Pharmaceutical compositions for sustained release of phenyephrine | |
CN1655766B (en) | Sustained release of guaifenesin combination drugs | |
RU2015106688A (en) | DRUGS AND METHODS FOR OBTAINING DRUGS FOR USE IN EMPTY DRAGES | |
ATE401075T1 (en) | MEDICINAL PRODUCT CONTAINING CYTISINE | |
CN111557923A (en) | Controllable timing zero-order drug release system and preparation method thereof | |
CN100544722C (en) | The levodropropizine pharmaceutical composition that uses in a kind of oral cavity | |
Bijank et al. | Formulation development studies of bilayer tablet glipizide: A novel and evolutionary approach in the treatment of diabetes | |
CN101693017A (en) | Medicament composition of levetiracetam and preparation process | |
SG161201A1 (en) | Production process for nsaid-containing lozenges, their compositions, their medicinal use | |
WO2007021033A1 (en) | Tablet having multiple drug-containing segments | |
RU2008150430A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF PIPERIDINOALKANOL AND ANTI-FLOW AGENT | |
Kumaran et al. | Formulation, development and evaluation of Levodopa-Carbidopa orally disintegration tablets | |
WO2006101462A3 (en) | Pharmaceutical preparation comprising perindopril erbumine and method of preparation and stabilisation thereof | |
PL377706A1 (en) | Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation | |
CN103690503B (en) | A kind of preparation method of double-layer tablet | |
WO2004078108A3 (en) | Fibrate tablet and method for the production thereof |